The latest CDC FluView report for Week 11 (ending March 21, 2026) shows a preliminary cumulative influenza hospitalization rate of 81.6 per 100,000 population via FluSurv-NET—third highest since 2010-11—driven by influenza A(H3N2), but with weekly rates dropping sharply to 1.1 per 100,000 amid nationally decreasing activity, low outpatient respiratory visits (2.9%), and test positivity at 11.5%. FluSight forecasts further declines in hospital admissions through early April, reflecting reduced transmission after a severe season peak. This positions trader consensus at 85% implied probability for an 80–85 final rate for Week 12, accounting for typical reporting delays; slight upside risk to 85–90 remains if delayed cases emerge, with next FluView update expected soon.
Polymarketデータを参照したAI生成の実験的な要約 · 更新日Flu Hospitalization Rate Week 12, 2026?
Flu Hospitalization Rate Week 12, 2026?
90–95 13%
85–90 5.5%
95以上 5.4%
<75 2.2%
NEW
NEW
Apr 3, 2026
<75
2%
75–80
35%
80–85
45%
85–90
14%
90–95
9%
95以上
5%
90–95 13%
85–90 5.5%
95以上 5.4%
<75 2.2%
NEW
NEW
Apr 3, 2026
<75
$179 Vol.
2%
75–80
$171 Vol.
35%
80–85
$367 Vol.
45%
85–90
$158 Vol.
14%
90–95
$3,012 Vol.
9%
95以上
$139 Vol.
5%
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.The latest CDC FluView report for Week 11 (ending March 21, 2026) shows a preliminary cumulative influenza hospitalization rate of 81.6 per 100,000 population via FluSurv-NET—third highest since 2010-11—driven by influenza A(H3N2), but with weekly rates dropping sharply to 1.1 per 100,000 amid nationally decreasing activity, low outpatient respiratory visits (2.9%), and test positivity at 11.5%. FluSight forecasts further declines in hospital admissions through early April, reflecting reduced transmission after a severe season peak. This positions trader consensus at 85% implied probability for an 80–85 final rate for Week 12, accounting for typical reporting delays; slight upside risk to 85–90 remains if delayed cases emerge, with next FluView update expected soon.
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
マーケット開始日： Mar 27, 2026, 11:13 AM ET
音量
$4,027終了日
Apr 3, 2026マーケット開始日
Mar 27, 2026, 11:13 AM ETResolver
0x69c47De9D...This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.The latest CDC FluView report for Week 11 (ending March 21, 2026) shows a preliminary cumulative influenza hospitalization rate of 81.6 per 100,000 population via FluSurv-NET—third highest since 2010-11—driven by influenza A(H3N2), but with weekly rates dropping sharply to 1.1 per 100,000 amid nationally decreasing activity, low outpatient respiratory visits (2.9%), and test positivity at 11.5%. FluSight forecasts further declines in hospital admissions through early April, reflecting reduced transmission after a severe season peak. This positions trader consensus at 85% implied probability for an 80–85 final rate for Week 12, accounting for typical reporting delays; slight upside risk to 85–90 remains if delayed cases emerge, with next FluView update expected soon.
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
音量
$4,027終了日
Apr 3, 2026マーケット開始日
Mar 27, 2026, 11:13 AM ETResolver
0x69c47De9D...The latest CDC FluView report for Week 11 (ending March 21, 2026) shows a preliminary cumulative influenza hospitalization rate of 81.6 per 100,000 population via FluSurv-NET—third highest since 2010-11—driven by influenza A(H3N2), but with weekly rates dropping sharply to 1.1 per 100,000 amid nationally decreasing activity, low outpatient respiratory visits (2.9%), and test positivity at 11.5%. FluSight forecasts further declines in hospital admissions through early April, reflecting reduced transmission after a severe season peak. This positions trader consensus at 85% implied probability for an 80–85 final rate for Week 12, accounting for typical reporting delays; slight upside risk to 85–90 remains if delayed cases emerge, with next FluView update expected soon.
Polymarketデータを参照したAI生成の実験的な要約 · 更新日
外部リンクに注意してください。
外部リンクに注意してください。
よくある質問